COM:AMYLYX
Amylyx Pharmaceuticals, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.amylyx.com/crunchbase
amylyx-pharmaceuticallinkedin
amylyxfounding date
Jan 01, 2014ipo date
Jan 07, 2022
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis...Show More